About the Authors
- Aaron D. Schimmer
-
* E-mail: aaron.schimmer@utoronto.ca
Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada
- Azra Raza
-
Affiliation Columbia University Medical Center, New York, New York, United States of America
- Thomas H. Carter
-
Affiliation The University of Iowa, Iowa City, Iowa, United States of America
- David Claxton
-
Affiliation Penn State, Hershey, Pennsylvania, United States of America
- Harry Erba
-
Affiliation University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Daniel J. DeAngelo
-
Affiliation Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
- Martin S. Tallman
-
Affiliation Leukemia Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, United States of America
- Carolyn Goard
-
Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada
- Gautam Borthakur
-
Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
Competing Interests
The authors have read the journal's policy and have the following competing interests: ADS, GB, and THC report research support from GeminX, during the conduct of the study; HE reports compensation from Celgene, Novartis, Celator, Sunesis, Seattle Genetics, and Incyte, outside the submitted work; AR, DC, DJD, CG, and MST have no competing interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ADS GB. Performed the experiments: ADS AR THC DC HE DJD MST CG GB. Analyzed the data: ADS AR THC DC GB. Contributed reagents/materials/analysis tools: ADS AR THC DC HE DJD MST GB. Wrote the paper: ADS AR THC HE DJD MST CG.